206 related articles for article (PubMed ID: 7690409)
1. Medullary thyroid carcinoma: prognostic factors.
Riddell DA; Lampe HB; Cramer H; Troster M
J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
4. [Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].
Böttger T; Potratz D; Gabbert H; Schernus B; Stöckle M; Klupp J; Junginger T
Chirurg; 1993 Feb; 64(2):122-9. PubMed ID: 8096455
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
6. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine therapy and after-care in thyroid gland carcinoma].
Feldkamp J
Praxis (Bern 1994); 1998 Mar; 87(11):389-93. PubMed ID: 9562815
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Bergholm U; Adami HO; Bergström R; Bäckdahl M; Akerström G
Acta Chir Scand; 1990 Jan; 156(1):37-46. PubMed ID: 2321439
[TBL] [Abstract][Full Text] [Related]
9. Need for a revised staging consensus in medullary thyroid carcinoma.
Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
11. [Low-risk thyroid carcinoma--therapy, follow-up and prognosis].
Sophocleous S; Ehrenheim C; Fischer J; Hundeshagen H
Nuklearmedizin; 1997 Apr; 36(3):93-102. PubMed ID: 9162908
[TBL] [Abstract][Full Text] [Related]
12. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
13. [Anaplastic thyroid carcinoma: diagnosis, treatment and prognosis].
Demidchik IuE; Fridman MV; Pisarenko AM
Vopr Onkol; 2007; 53(1):37-45. PubMed ID: 17649732
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
16. [Is age a prognostic factor in differentiated carcinoma of the thyroid gland? (author's transl)].
Proye C; Maes B; Lagache G; Fossati P; Linquette M
Nouv Presse Med; 1981 Dec; 10(45):3701-4. PubMed ID: 7322903
[TBL] [Abstract][Full Text] [Related]
17. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in medullary thyroid carcinomas.
Schröder S; Dralle H
Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
[TBL] [Abstract][Full Text] [Related]
20. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]